On the path to understanding the nature of cancer

Biochemistry (Moscow)

Volumn 73, Issue 5, 2008, Pages 487-497

  Abelev, G I ^a   Eraiser, T L ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Carcinogenesis; Epithelial mesenchymal transition; Oncogenes; Precancer; Progression; Protooncogenes; Suppressors

Indexed keywords

DNA; GENES; ONCOLOGY; RNA; VIRUSES;

CARCINOGENESIS; EPITHELIAL-MESENCHYMAL TRANSITION; ONCOGENES; PRECANCER; PROGRESSION; PROTOONCOGENES; SUPPRESSORS;

TUMORS;

ANIMAL; CARCINOMA; GENETICS; HUMAN; METABOLISM; NEOPLASM; ONCOGENE; PATHOLOGY; PRECANCER; PROTO ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; ONCOGENES; PRECANCEROUS CONDITIONS; PROTO-ONCOGENES;

EID: 44649139171     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297908050015     Document Type: Review

References (60)

1. Weinberg, R. (2006) The Biology of Cancer, Garland Science, New York.
2. Shabad, L. M. (1967) Precancer in Experimental and Morphological Aspects [in Russian], Meditsina, Moscow.
3. IARC Monographs on the Evaluations of Carcinogenic Risks for Humans (1995) Vol. 53, Hepatitis Viruses, IARC, Lion, France.
4. The EUROGAST Study Group (1993) Lancet, 341, 1359-1362.
5. Abelev, G. I. (1979) in Tumor Growth as a Problem of Developmental Biology (Gelstein, V. I., ed.) [in Russian], Nauka, Moscow, pp. 148-173.
6. Tenen, D. G. (2003) Nat. Rev. Cancer, 3, 89-101.
7. Huntly, B. J. P., and Gilliland, G. (2005) Nat. Rev., 5, 311-321.
8. Moore, K. A., and Lemischka, I. R. (2006) Science, 311, 1880-1885.
9. Weinberg, R. (2006) The Biology of Cancer, Chap. 16, The Rational Treatment of Cancer, Garland Science, New York, pp. 725-795.
10. Dean, M., Fojo, T., and Bates, S. (2005) Nat. Rev. Cancer, 5, 275-284.
11. Tenen, D. G., Hromas, R., Licht, J. D., and Zany, D.-E. (1997) Blood, 90, 489-519.
12. Abelev, G. I. (2007) in Clinical Oncohematology (Volkova, M. A., ed.) [in Russian], 2nd Edn., Meditsina, Moscow, pp. 167-176.
13. Olovnikov, A. M. (1971) Dokl. Akad. Nauk SSSR, 201, 1496-1499.
14. Daser, A., and Rabbitts, T. (2004) Genes Dev., 18, 965-974.
15. Weinberg, R. (2006) The Biology of Cancer, Chap. 10, Eternal Life: Cell Immortalization, Garland Science, New York, pp. 725-795.
16. Duesberg, P., Fabarius, A., and Hehlmann, R. (2004) Life, 56, 65-81.
17. Laconi, S., Pillai, S., Porcu, P. P., Shafritz, D. A., Pani, P., and Laconi, E. (2001) Am. J. Pathol., 158, 771-777.
18. Laconi, S., Pani, P., Pillai, S., Pasciu, D., Sarma, D. S. R., and Laconi, E. (2001) Proc. Natl. Acad. Sci. USA, 98, 7807-7811.
19. Sell, S., Hunt, J. M., Knoll, B. J., and Dunsford, H. A. (1987) Adv. Cancer Res., 48, 37-111.
20. Greenberg, A. K., Yee, H., and Rom, W. N. (2002) Respir. Res., 3, 20-30.
21. Cozzio, A., Passegue, E., Ayton, P. M., Karsunky, H., Cleary, M. L., and Weissman, I. L. (2003) Genes Dev., 17, 3029-3035.
22. Weinberg, R. (2006) The Biology of Cancer, Chap. 8, Rb and Control of Cell Cycle Clock, Garland Science, New York, pp. 255-306.
23. Knudson, A. G. (1971) Proc. Natl. Acad. Sci. USA, 68, 820-823.
24. Calderon-Margalit, R., and Paltiel, O. (2004) Int. J. Cancer, 112, 357-364.
25. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M., and Bos, J. L. N. (1988) Engl. J. Med., 319, 525-532.
26. Daley, G. Q., van Etten, R. A., and Baltimore, D. (1990) Science, 247, 824-830.
27. Weinberg, R. (2006) The Biology of Cancer, Chap. 9, P53 and Apoptosis: Master Guard and Executor, Garland Science, New York, pp. 307-356.
28. Kern, S. E. (1993) J. Nat. Cancer Inst., 85, 1020-1021.
29. Bhowmick, N. A., and Moses, H. L. (2005) Curr. Opin. Genet. Dev., 15, 97-101.
30. Hussain, S. P., and Harris, C. C. (2007) Int. J. Cancer, 121, 2373-2380.
31. Mueller, M. M., and Fusenig, N. E. (2004) Nat. Rev. Cancer, 4, 839-849.
32. Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F., and Loguercio, C. (2007) Int. J. Cancer, 121, 2381-2386.
33. Nedospasov, S. A., and Kuprash, D. V. (2004) in Carcinogenesis (Zaridze, D. G., ed.) [in Russian], Meditsina, Moscow, pp. 158-168.
34. Li, Q., Withoff, S., and Verma, I. M. (2005) Trends Immunol., 26, 318-325.
35. Zaridze, D. G. (2004) in Carcinogenesis (Zaridze, D. G., ed.) [in Russian], Meditsina, Moscow, pp. 29-85.
36. Karamysheva, A. F. (2004) in Carcinogenesis (Zaridze, D. G., ed.) [in Russian], Meditsina, Moscow, pp. 429-447.
37. Weinberg, R. (2006) The Biology of Cancer, Chap. 13, Dialogue Replaces Monologue: Heterotypic Interactions and the Biology of Angiogenesis, Garland Science, New York, pp. 527-587.
38. Stetler-Stevenson, W., and Yu, A. E. (2001) Sem. Cancer Biol., 11, 143-152.
39. Zilber, L. A., Irlin, I. S., and Kiselev, F. L. (1975) Evolution of the Virus-Genetic Theory of Tumor Arising, Chap. 8, Endogenous Viruses and "Normal" Therapy [in Russian], Nauka, Moscow, pp. 242-310.
40. Weinberg, R. (2006) The Biology of Cancer, Chap. 3, Tumor Viruses, Garland Science, New York, pp. 57-90.
41. Altstein, A. D. (1973) Zh. Vsesoyuzn. Khim. Obshch. im. Mendeleeva, 18, 631-636.
42. Weiss, R., Teich, N., Varmus, H., and Coffin, J. (eds.) (1982) RNA Tumor Viruses, Cold Spring Harbor, NY, pp. 1-396.
43. Bentvelzen, P. (1968) in Genetic Controls of the Vertical Transmission of the Muhlbock Mammary Tumor Virus in the GR Mouse Strain, Hollandia Publisher Co., Amsterdam, p. 1.
44. Tatosyan, A. G. (2004) in Carcinogenesis (Zaridze, D. G., ed.) [in Russian], Meditsina, Moscow, pp. 103-124.
45. Weinberg, R. (2006) The Biology of Cancer, Chap. 4, Cellular Oncogenesis, Garland Science, New York, pp. 91-118.
46. Weinberg, R. (2006) The Biology of Cancer, Chap. 7, Tumor Suppressor Genes, Garland Science, New York, pp. 209-254.
47. Altstein, A. D. (2004) in Carcinogenesis (Zaridze, D. G., ed.) [in Russian], Meditsina, Moscow, pp. 251-274.
48. Fleishman, E. V. (2007) in Clinical Oncohematology (Volkova, M. A, ed.) [in Russian], 2nd Edn., Meditsina, Moscow, pp. 370-408.
49. Hanahan, D., and Weinberg, R. A. (2000) Cell, 100, 57-70.
50. Hallek, M., Bergsagel, P. L., and Anderson, K. C. (1998) Blood, 91, 3-21.
51. Kuppers, R. (2005) Nat. Rev. Cancer, 5, 251-262.
52. Kopnin, B. P. (2004) in Encyclopedia of Clinical Oncology (Davydov, M. I., ed.) [in Russian], RLS-Press, pp. 34-53.
53. Schwartz, M. A. (1997) J. Cell Biol., 139, 575-578.
54. Ruoslahti, E. (1999) Adv. Cancer Res., 76, 1-20.
55. Schmeichel, K. L., and Bissell, M. J. (2003) J. Cell Sci., 116, 2377-2388.
56. Bissell, M. J., Radisky, D. C., Rizki, A., Weaver, V. M., and Petersen, O. W. (2002) Differentiation, 70, 537-546.
57. Radisky, D., and Bissel, M. J. (2004) Science, 303, 775-777.
58. Abelev, G. I., and Lazarevich, N. L. (2006) Adv. Cancer Res., 95, 61-113.
59. Thiery, J. P. (2002) Nat. Rev. Cancer, 2, 442-454.
60. Javaherian, A., Vaccariello, M., Fusenig, N. F., and Garlick, J. A. (1998) Cancer Res., 58, 2200-2208.